Showing 601 - 620 results of 146,546 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 10 ((nm decrease) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 601
  2. 602

    Rescue of <i>MBNL</i>1 e5 and <i>MBNL</i>2 e5 and e8 mis-splicing by erythromycin lactobionate treatment at 10 DPI. by Mougina K. Eltahir (12988153)

    Published 2022
    “…Note the decreased inclusion of <i>MBNL</i>1 e5 (+e5) and <i>MBNL</i>2 e5 (+e5) in DM1 hiNeurons treated with 35 or 65 μM erythromycin for 48 h relative to placebo treated cells. …”
  3. 603

    Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5. by Fabián Santos (8174028)

    Published 2023
    “…<p>Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5.…”
  4. 604
  5. 605

    Exposures to PM<sub>2.5</sub>, PM<sub>10</sub> and Nitrogen dioxide. by Chika Edward Uzoigwe (20460686)

    Published 2024
    “…A sizeable proportion also had annual mean exposures that surpassed the WHO PM<sub>10</sub> (14.8%) and nitrogen dioxide (63%) recommended thresholds. …”
  6. 606
  7. 607
  8. 608

    List of Included studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  9. 609

    The search strategy in three databases. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  10. 610

    NIH score. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  11. 611

    List of excluded studies. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  12. 612
  13. 613
  14. 614
  15. 615
  16. 616
  17. 617
  18. 618
  19. 619
  20. 620